￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Targeted treatment drug for non-small cell lung cancer - Crizotinib (Xalkori)

2025-10-19 11:44:20

Check Details
What should I do if I miss a dose of osimertinib? Will long-term treatment with osimertinib lead to drug resistance

2025-10-19 11:44:20

Check Details
Summary of the specific efficacy of entrectinib in treating different diseases

2025-10-19 11:44:20

Check Details
The clinical data of cabozantinib is impressive, and cabozantinib is cheaper to buy through this channel!

2025-10-19 11:44:20

Check Details
Is afatinib effective in treating lung cancer? How long does it usually take to get results

2025-10-19 11:44:20

Check Details
How should Erlotinib and Tarceva be used to treat lung cancer? What are the precautions

2025-10-19 11:44:20

Check Details
The efficacy of gefitinib has been confirmed and has been included in domestic medical insurance

2025-10-19 11:44:20

Check Details
Erlotinib prolongs patient survival by up to 11 months!

2025-10-19 11:44:20

Check Details
The third generation of EGFR-targeted drugs, a detailed explanation of osimertinib in one article

2025-10-19 11:44:20

Check Details
Compared with previous generation drugs, dacomitinib extends the survival period by more than half!

2025-10-19 11:44:20

Check Details
Compared with the previous generation of drugs, afatinib has more significant efficacy_ Kanghule

2025-10-19 11:44:20

Check Details
Tepotinib is approved for marketing in China, which is of great significance

2025-10-19 11:44:20

Check Details
Category
相关知识